Physiological implication of the SLC6A4 gene in the cardiovascular system includes the proliferation of vascular smooth muscle cell, which is a part of the atherosclerosis process [24–26], vasoconstriction of the arterial wall, endothelial damage and pulmonary arterial hypertension [27, 28]. This evidence concerns the gene SLC6A4 and pulmonary arterial hypertension.